ArticleGeroScience2021

Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice.

Stefano Tarantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.